In an in vitro experiment, the authors used cell proliferation assays with NIH:OVCAR3 (MUC16 knockdown) and SKOV3 (MUC-16-expressing) cells to investigate the tumour initiation capacity of MUC16 knockout cell lines. The gene discussed is MUC16; the disease is neoplasm.